Niagen Bioscience, Inc. (NAGE)
6.23
+0.04
(+0.65%)
USD |
NASDAQ |
Jan 20, 14:50
Niagen Bioscience EPS Diluted (Quarterly): 0.0528 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 0.6601 |
| Corcept Therapeutics, Inc. | 0.1621 |
| Liquidia Corp. | -0.0409 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Caris Life Sciences, Inc. | 0.0862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.578M |
| Revenue (Quarterly) | 33.99M |
| Total Expenses (Quarterly) | 29.41M |
| Enterprise Value | 432.76M |
| Gross Profit Margin (Quarterly) | 64.52% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 3.91% |
| Operating Earnings Yield | 3.67% |
| Normalized Earnings Yield | 3.907 |